Cyagen is excited to announce our participation in the 15th World Bispecific Summit in Boston on September 3-5, 2024. 

Join us at Table #5, where our experts will be available to discuss your drug development plans and introduce you to Cyagen's HUGO-Ab^TM & Biointron's AbDrop^TM

This is your opportunity to connect with our experts and explore how we can accelerate your antibody drug discovery journey. We’re teaming up with Biointron to showcase how our collaboration can make 1+1 > 2 for your research.

Have questions for our specialists or want more information?

Request a meeting in-person at 15th World Bispecific Summit to discuss your project.

Click here to book the in-person meeting!

Contact us for a free consultation on your HUGO-Ab^TM projects.  

Cyagen is a global leader in genetically modified rodent models and cell and gene therapy solutions, specializing in areas like immuno-oncology and neuroscience. Our HUGO-Ab™ mice, developed with TurboKnockout® technology, produce fully human antibodies with high affinity and low immunogenicity, accelerating drug discovery. The HUGO-Light™ model enhances bispecific antibody development and drugability, making Cyagen a key partner in innovative therapeutic research.